Olkhovych Nataliia, Pichkur Nataliia, Mytsyk Nataliia, Tonin Rodolfo, Kormoz Svitlana, Hregul Iryna, Samonenko Nataliia, Shklyarskaya Tetiana, Olkhovych Volodymyr, Buryak Olexandr, Morrone Amelia, Gorovenko Nataliia
Department of Genetic Diagnostics National Scientific Center, Institute of Cardiology, Clinical and Regenerative Medicine M.D. Strazheska, National Academy of Medical Sciences of Ukraine Kyiv Ukraine.
Laboratory of Medical Genetics National Children's Hospital OHMATDYT, Ministry of Health of Ukraine Kyiv Ukraine.
JIMD Rep. 2024 May 14;65(4):272-279. doi: 10.1002/jmd2.12423. eCollection 2024 Jul.
The neuronal ceroid lipofuscinosis type 2 (CLN2) is a heterogeneous group of neurodegenerative lysosomal storage disorders caused by autosomal recessive inheritance of two pathogenic variants in trans in the gene. Classical late-infantile CLN2 disease has a very well-defined natural history. However, a small number of patients with TPP1 enzyme deficiency present a later onset or protracted disease course within this group there are phenotypic variants. Our work aimed to identify pathological variants in the gene that conditioned the development of CLN2 disease in Ukrainian patients, to compare these variants with those found in patients from other European and non-European regions, and to make genotype-phenotype associations for this disease. The phenotypes and genotypes of the 48 CLN2-affected individuals belonging to 43 families were profiled through clinical data collection, enzyme analysis, and genotyping. In most patients, genotype and phenotype correlation are in keeping with the data of previous studies. The clinical signs of the disease in patients with new, previously undescribed variants, allowed us to augment existing data about genotype-phenotype correlations for CLN2 disease. The combination of genotype and clinical form of the disease demonstrated that predicting the type and clinical course of the disease based on genotype is very complicated. The data we obtained supplements existing information on genotype-phenotypic correlations in this rare disease, which, in turn, lays the foundation for a personalized approach to the management of this disease.
2型神经元蜡样脂褐质沉积症(CLN2)是一组异质性神经退行性溶酶体贮积症,由该基因中两个致病变异的常染色体隐性遗传引起。典型的晚发性婴儿型CLN2疾病有非常明确的自然病程。然而,少数TPP1酶缺乏的患者发病较晚或病程迁延,在这一组中有表型变异。我们的工作旨在确定导致乌克兰患者CLN2疾病发生的该基因的病理变异,将这些变异与其他欧洲和非欧洲地区患者中发现的变异进行比较,并建立该疾病的基因型-表型关联。通过临床数据收集、酶分析和基因分型,对43个家庭的48名受CLN2影响个体的表型和基因型进行了分析。在大多数患者中,基因型和表型的相关性与先前研究的数据一致。具有新的、先前未描述变异的患者的疾病临床体征,使我们能够增加关于CLN2疾病基因型-表型相关性的现有数据。疾病的基因型和临床形式的结合表明,基于基因型预测疾病的类型和临床病程非常复杂。我们获得的数据补充了关于这种罕见疾病基因型-表型相关性的现有信息,这反过来又为该疾病的个性化管理方法奠定了基础。